Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Pricer AB decides on a repurchase program for own shares to hedge obligations for the company's incentive programs

Pricer AB has decided to introduce a repurchase program for own shares in order to secure obligations for the company's incentive program. The repurchase program shall comprise a maximum of 400,000 Class B shares that may be repurchased for a cost that does not exceed a total of SEK 20 million and runs until next year's Annual General Meeting.With the support of authorization from the 2020 Annual General Meeting, the Board of Directors of Pricer AB has decided to introduce a repurchase program for own shares. The repurchases take place for the purpose determined by the Annual General

Insr: Cancellation of upcoming interest payment

With reference to the published third quarter 2020 results, Insr Insurance Group ASA announces that for the Tier 1 bond with ISIN NO00108344880, interest payments during 2021 are cancelled. Clause 3.6.1 of the loan agreement gives the company the option of cancelling interest payments.This notification is also sent to the bonds' trustee, Nordic Trustee.For further information, please contact:Anne B. Knudtzon,SVP Business Controlling & Investor RelationsT: +47 926 10 606E: InvestorRelations@insr.ioInsr Insurance Group ASA was established in 2009 and is an independent insurance

Initiator Pharma - First patient dosed in Phase 2a trial with IP2018

Initiator Pharma A/S, a clinical-stage biotech company, today announced that the first patient was dosed in its Phase 2a clinical trial with IP2018 to treat psychogenic sexual dysfunction. IP2018 is Initiator Pharma's second Phase 2 asset and is complementary to IPED2015 for which positive Phase 2a data on Organic Erectile dysfunction was reported earlier this year. Initiator Pharma has received a commitment from Innovation Fund Denmark to support the clinical development of IP2018.IP2018 is being developed for the treatment of sexual dysfunction in patients with major depressive disorder

Contractbook Raises $9.4 Million in Series A Funding Led by Bessemer Venture Partners

Danish software company emerges from stealth mode with 300% YOY revenue growthNew York, NY -- December 9, 2020 -- Contractbook, a legal tech automation company based in Copenhagen, announced today that it has closed on a $9.4 million Series A investment round, led by Bessemer Venture Partners with participation from existing investors, including Gradient Ventures. Less than a year ago, Gradient Ventures, which is Google’s AI-focused venture fund, led the company’s €3.5 million seed round. Companies in every industry are motivated to reduce manual and paper-based processes. Yet, many of

Sale of property in Örebro

Catena has signed an agreement to divest the Godsvagnen 6 property.9 December 2020, 3:00 p.m. CET The Godsvagnen 6 property in the Municipality of Örebro has been sold by Catena with a purchase consideration of SEK 157 million, which exceeds the valuation as of the third quarter by about 5 percent. The buyer is a Swedish government organisation. The property has a lettable area of approximately 19,600 square metres and is situated on a plot of 60,700 square metres. The rental value amounts to about SEK 12 million, with Catena having relinquished ownership in December.  “This sale

Decisions at Securitas’ Extraordinary General Meeting

Securitas AB (publ) held an Extraordinary General Meeting (EGM) today, on December 9, 2020.In order to reduce the risk of spreading the coronavirus and to comply with regulations and general guidelines issued by the authorities, the EGM was, in accordance with temporary legislation, held only by postal voting. DividendThe EGM resolved in accordance with the Board’s proposal to pay a dividend of SEK 4.80 per share. Record date for the dividend is Friday December 11, 2020 and the dividend is estimated to be distributed by Euroclear Sweden AB starting on Wednesday December 16, 2020.

Expectations for revenue full year 2020 and guidance for 2021

Company Announcement No. 19-2020Copenhagen, December 9, 2020 As a result of the covid-19 pandemic, schools and educational institutions in some of the Company’s main markets continue to be closed, and/or students are being taught outside the physical classroom. This situation continues to impact the Company’s international sales also in Q4, which under normal circumstances are the best-selling quarter. The Company therefore adjusts the expectations for the revenue in 2020. The Company expects the revenue for the full year 2020 to be MDKK 6.0 - 7.0, instead of the previously

TOMRA: NEW EUR 150M LOAN FACILITY

TOMRA Systems ASA has today entered into an EUR 150 million Multicurrency Revolving Credit Facility with DNB, Danske Bank, Nordea Bank and Swedbank as lending banks. The facility has a tenor of 3+1+1 years. The funds will be used to refinance existing debt and for general corporate purposes. The existing EUR 60M facility, expiring in April 2021 and EUR 70M facility expiring in December 2021 will be cancelled. For further information please contact Deputy CEO and CFO Espen Gundersen, telephone +47 97 68 73 01.  Asker, 9 December 2020 TOMRA Systems ASA

Saab receives order for an integrated ground based air defence solution for Sweden

Saab today signed a contract with the Swedish Defence Materiel Administration and received an order for an integrated sensor and command and control system for use with ground based air defence. The order value is approximately 2.1 billion SEK and the contract period is 2020-2025.The order includes a number of Saab’s multifunctional radar Giraffe 4A and upgrades of the Swedish Armed Forces’ existing Giraffe AMB surface radars. Saab will also update existing and deliver additional command and control systems, as well as provide extensive integration of the air defence battalions’ fire units.

Balco’s Chairman of the Board Tomas Johansson declines re-election

Due to increased involvement in Segulah Balco's Chairman of the Board Tomas Johansson has informed the Nomination Committee that he does not intend to make himself available for re-election at the next Annual General Meeting. Recruitment of a new Chairman of the Board starts immediately. Tomas Johansson resigns as Chairman and Board member at the Annual General Meeting on 25 May 2021.   For more information, please contact: Carl-Mikael Lindholm, Chairman of the Nomination Committee,Phone: +46 (0)73 674 53 28

Major shareholder announcement

Company announcement 16/2020   In accordance with section 30 of the Capital Markets Act, HusCompagniet A/S (the “Company”) hereby announces that Danske Bank A/S has notified the Company that Danske Bank A/S through Danica Pension Livsforsikringsselskab, DI Inst. Afd. Danica Pension Aktier, Investeringsforeningen Danske Invest and Danske Invest SICAV, directly and indirectly, holds 1,570,316 shares of nominal value DKK 5 each in the Company, corresponding to 7.85 % of the entire share capital, as well as voting rights in the Company, corresponding to 8.20 % of the total voting rights

New plan period on share-based long-term incentive plan for Caverion’s key employees

Caverion Corporation Stock exchange release 9 December 2020 at 3.00 p.m. EETNew plan period on share-based long-term incentive plan for Caverion’s key employees Caverion's Board of Directors has approved the commencement of a new plan period 2021-2023 in the share-based long-term incentive scheme. The scheme is based on a performance share plan (PSP) structure targeted to Caverion’s management and selected key employees. The Board has at the same time approved the commencement of a new plan period 2021-2023 in the Restricted Share Plan (RSP) structure, which is a complementary share-

Isofol reaches 440 patients in global Phase III AGENT study

GOTHENBURG, Sweden, December 9, 2020 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) announces that 440 patients has been successfully recruited in the global Phase III AGENT study for the treatment for advanced colorectal cancer.Isofol's drug candidate, arfolitixorin, is evaluated for treatment of patients with first-line metastatic colorectal cancer (mCRC). The AGENT study is currently being conducted in the U.S., Canada, Europe, Australia and Japan at more than 90 clinics. The primary endpoint of the AGENT study is overall response rate (ORR).

New contract award in Brazil

The DOF Group is pleased to announce a new contract award for its fleet in Brazil for Petróleo Brasileiro S.A. ("Petrobras"). The AHTS18000 Skandi Rio will support Petrobras' exploration and production activities on the Brazilian continental shelf. The vessel is owned and operated by Norskan Offshore Ltda. while DOF Subsea Brasil Servicios Ltda.  will be responsible for the ROV operations. Both companies are 100% owned subsidiaries of DOF ASA. The contract duration is for 3+1-year with expected commencement in December/January. Skandi Rio is a Brazilian built and flagged AHTS vessel

ICA Gruppen presents strategic priorities and estimated margin effect from online

Today, 9 December 2020, ICA Gruppen is arranging a Capital Markets Day in digital format. During the Capital Markets Day ICA Gruppen’s strategic step-change areas will be presented. ICA Gruppen also reports that the start-up of ICA Sweden’s new online solution, which is implemented to meet the rapid growth online, will have an estimated margin effect of approximately -0.1 % for ICA Sweden during 2021 and less than -0.1 % in 2022.The new market conditions brought about by the Covid-19 pandemic have led to a greater focus on price value, new ways of working, tougher requirements for

Biohit Oyj’s Financial Reporting and Annual General Meeting in 2021

Biohit Oyj Financial calendar, December 09, 2020 at 4:30 pm local time (EET)  · Biohit Oyj will release its financial statements for 2020 on Wednesday 17[th] of February 2021 at 9:30 am.   · The Annual Report, which contains the Financial Statements for 2020 and the Report of the Board of Directors, will be published approximately during week 12. · Biohit Oyj’s Annual General Meeting has been planned for Wednesday 21[th] of April 2021 at 5:00 pm. The Board of Directors will call the General Meeting at a later date. · Half year financial report for period January-June (H1)

WindowMaster International A/S: The profit outlook for 2020 beats forecast and high growth expectations for 2021 confirmed

Despite the exceptional uncertainty caused by the coronavirus pandemic and Brexit – WindowMaster International A/S’s profit outlook for 2020 looks stronger than communicated in the IPO company description published on the 6th of October 2020.This positive profit outlook is driven by a higher topline growth than anticipated for Q4. The higher topline is spread over most markets but with substantial pick up in the United Kingdom and also increased growth in North America.  Instead of a topline in the range of 185-189m DKK for the full year of 2020 the outlook is now between 188-

NPRO: Final result of the subsequent offering

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Oslo, 9 December 2020: Reference is made to the stock exchange announcements by Norwegian Property ASA ("NPRO" or the "Company") on 8 December 2020 regarding the preliminary results of the subsequent offering of up to 2,492,143 new shares (the "Offer Shares"), each with a par value of

Semcon even stronger in sustainability

Semcon has a long history of sustainable technology development. Now the Group is becoming even stronger by recruiting Heidi Östlund as its new Head of Sustainability. This recruitment is a part of Semcon's strategic emphasis on reinforcing its position in the field.Since the company was founded in 1980, Semcon's efforts have always been focused on people before technology, and prioritising the benefits of technology. This is done by updating existing products and services, developing new solutions and creating new strategies for a sustainable future. Semcon is also involved in the

Save the date: Calliditas to host a Capital Markets Day in Stockholm, Sweden, on January 20, 2021

Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that the company will host a Capital Markets Day in Stockholm, Sweden, on January 20, 2021 for investors, analysts and media.Presentations will be made by members of Calliditas’ management team as well as invited key opinion leaders. The program will include an overview of the company’s clinical development program, with a review of the recent successful topline data readout from the Phase 3 clinical study NefIgArd; the lead candidate drug Nefecon’s regulatory path towards potential market approval; an update on preparations

Towards CO₂ neutrality for climate action – interview with TePe’s Marketing & Innovation Director

Working in line with the UN Sustainable Development Goal of Climate Action requires dedication, ambitious targets and a creative approach. We spoke with Helena Ossmer Thedius, Marketing and Innovation Director at TePe, to find out more about the company’s journey towards CO₂ neutrality.TePe has decided to reach for CO₂ neutrality for all products in 2022. What is the reason behind setting such an ambitious goal? – Taking action to combat climate change and its impacts is one of the greatest challenges of our time. To tackle this, we need to reduce carbon emissions and move towards a

Fortum Corporation: Managers' transactions – Markus Rauramo

FORTUM CORPORATION STOCK EXCHANGE RELEASE 9 DECEMBER 2020 AT 13:55 EET Release category: Managers’ transactions Person subject to the notification requirementName: Rauramo, MarkusPosition: Chief Executive OfficerIssuer: Fortum CorporationLEI: 635400IUIZZIUJSAMF76 Notification type: INITIAL NOTIFICATIONReference number: 635400IUIZZIUJSAMF76_20201209113713_2 Transaction date: 2020-12-09Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009007132Nature of the transaction: ACQUISITION Transaction details(1): Volume: 100 Unit price: 18.295 EUR(2):

Saga Pure Asa: Share Capital Increase Registered

Reference is made to the stock exchange notice from Saga Pure ASA (the "Company") dated 30 November 2020 regarding completion of a private placement of 34,000,000 new shares in the Company, raising gross proceeds of NOK 54.4 million (the "Private Placement"). The share capital increase pertaining to the Private Placement has now been registered with the Norwegian Register of Business Enterprises. The new registered share capital of the Company is NOK 3,741,498.31 divided by 374,149,831 shares, each with a par value of NOK 0.01. The new shares issued in the Private Placement will

Retrospective study on Attana’s track record published in IBI shows extraordinary results

Today, a retrospective study on Attana’s track record was published in IBI (International Biopharmaceutical Industry). The study evaluates the outcome of all the 77 drug candidates Attana has analyzed for customers in the pre-clinical phase.The result of the study shows Attana has had an accuracy of 100% in determining which candidates will succeed in clinical trials, outperforming the company’s previously communicated expectations. The findings suggest that Attana’s proprietary technology and validation process has improved clinical trial success rates by over 80%. If the accuracy of the

There are no items matching the current filter
There are no more items matching the current filter
Back to top